What You Need to Know about the Link Between Gleevec and Heart Failure

Novartis Oncology has announced that it is mailing information to U.S. doctors, informing them of a possible link between Gleevec (imitinib mesylate) and congestive heart failure.

Gleevec, an oral tyrosine kinase inhibitor approved by the Food and Drug Administration in 2001, is prescribed for gastrointestinal stromal tumors (GIST) and chronic myeloid leukemia.

Nature Medicine published the results of animal studies that suggested that a side effect of Gleevec may be cardiac dysfunction.

see also:

Drug Safety Advisories Letter to Health Care Professionals about Gleevec and Heart Failure
FDA sends letter to doctors about Gleevec and heart failure

2006 FDA Health Advisories Jury: Prempro Caused Woman's Breast Cancer
U.S. Jury Finds that Wyeth Drug Prempro Caused a Woman's Breast Cancer

Foods FDA Announces Beef Recall Due to E. coli Concern
FDA Announces Beef Recall in 7 States Due to E. coli Concern